IRVINE, Calif., Nov. 2, 2006 (PRIMEZONE) -- A report detailing the opportunities for investors of biotech, pharmaceutical, and health care technologies in today's stock market has been made available at SmallCapSentinel.com. The report, "The Silver Tsunami: Baby Boomers & Biotech Breakthroughs" is authored by the SmallCap Sentinel editorial team.
"With the enormous demographic of baby boomers aging quickly, savvy investors are looking for opportunities that address this massive group," stated SmallCap Sentinel D.R. Clark. "Many of those exist within the small and microcap sectors of the market."
Additionally, the editors of leading financial couriers StockUpTicks.com and SmallCap Sentinel will be attending the prestigious Westergaard SmallCap conference to review and examine various public companies showcased in that venerable forum held November 6, 2006 at the Waldorf-Astoria Hotel in New York City. The conference offers a unique opportunity for investment professionals to meet with top-rated companies, industry practitioners and several senior analysts.
For more information on the Westergaard SmallCap conference please visit www.westergaardsmallcap.com
The report features information on various smallcap companies presenting at the Westergaard including AspenBio Pharma, Inc. (OTCBB:APNB), Chembio Diagnostics Inc. (OTCBB:CEMI), Lumera Corp. (Nasdaq:LMRA), and Memry Corp. (AMEX:MRY).
Individuals may register to receive free future reports regarding emerging smallcap companies at: http://stockupticks.com/register.html
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that will affect results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to accuracy or completeness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement provided for information purposes only and shouldn't be used as basis for any investment decision. MP has not been compensated by any company referenced herein. MP is not an investment advisor and this report isn't investment advice. There is an inherent conflict of interest as to MP's ability to remain objective in its communication regarding the subject companies.